Mandy E. Jongeneelen

Leiden, ZH 2333CN, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Small molecule-constrained paratope mimetic bicyclic peptides as potent inhibitors of group 1 and 2 influenza A virus hemagglutinins.

Small molecule-constrained paratope mimetic bicyclic peptides as potent inhibitors of group 1 and 2 influenza A virus hemagglutinins.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 24, 2026

A group 1 hemagglutinin stem vaccine elicits broad humoral responses against influenza in phase 1/2a study.

A group 1 hemagglutinin stem vaccine elicits broad humoral responses against influenza in phase 1/2a study.

Journal: Nature communications

Published: December 19, 2025

VHH antibody loop guides design of a synthetic macrocyclic peptide that potently blocks influenza virus membrane fusion.

VHH antibody loop guides design of a synthetic macrocyclic peptide that potently blocks influenza virus membrane fusion.

Journal: Npj viruses

Published: September 09, 2025

De novo design of D-peptide ligands: Application to influenza virus hemagglutinin.

De novo design of D-peptide ligands: Application to influenza virus hemagglutinin.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: June 27, 2025

The definition of vitality-the perspectives of Dutch older persons.

The definition of vitality-the perspectives of Dutch older persons.

Journal: BMC public health

Published: August 18, 2023

Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen.

Enhancing breadth and durability of humoral immune responses in non-human primates with an adjuvanted group 1 influenza hemagglutinin stem antigen.

Journal: NPJ vaccines

Published: June 08, 2023

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.

Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence features.

Journal: Nature communications

Published: May 16, 2023

Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trials.

Durable antibody responses elicited by 1 dose of Ad26.COV2.S and substantial increase after boosting: 2 randomized clinical trials.

Journal: Vaccine

Published: February 01, 2022

Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regions.

Universal stabilization of the influenza hemagglutinin by structure-based redesign of the pH switch regions.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 30, 2021

Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.

Immunogenicity and efficacy of one and two doses of Ad26.COV2.S COVID vaccine in adult and aged NHP.

Journal: The Journal of experimental medicine

Published: December 31, 2020

A small-molecule fusion inhibitor of influenza virus is orally active in mice.

A small-molecule fusion inhibitor of influenza virus is orally active in mice.

Journal: Science (New York, N.Y.)

Published: December 07, 2017

Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin.

Universal protection against influenza infection by a multidomain antibody to influenza hemagglutinin.

Journal: Science (New York, N.Y.)

Published: September 27, 2017

Showing 1-12 of 14

Last Updated: 09/26/2026